What to Know About COVID-19 Vaccines for Kids
Press Releases, Moderna: “Moderna Announces First Participants Assayed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Pediatric Population”, “Moderna Announces First Participants Assayed in Phase 2/3 Study of the adolescent COVID-19 vaccine candidate. “
Clinical Trials.gov: “Study to describe the safety, tolerability, immunogenicity and efficacy of RNA vaccine candidates against COVID-19 in healthy individuals.”
Tina Tan, MD, pediatric infectious disease specialist, Ann & Robert H. Lurie Children’s Hospital, Chicago; professor of pediatrics, Feinberg School of Medicine, Northwestern University.
Sean O’Leary, MD, professor of pediatrics, University of Colorado Anschutz Medical Campus; vice-chairman, American Academy of Pediatrics Committee on Infectious Diseases.
Yvonne Maldonado, MD, chair, American Academy of Pediatrics Committee on Infectious Diseases; chief of pediatric infectious diseases, Stanford University School of Medicine, Stanford, California.
American Academy of Pediatrics: “Children and COVID-19: State Level Data Report”.
Medrxiv.org: “Anti-SARS-CoV-2 Antibodies Detected in Human Breast Milk After Vaccination,” “Neonatal Anti-SARS-CoV-2 Antibodies Detected in Cord Blood After Maternal Vaccination.”
Our sincere thanks to